APA (7th ed.) Citation

McNally, P., Linnane, B., Williamson, M., Elnazir, B., Short, C., Saunders, C., . . . Cox, D. W. (2023). The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting. Respiratory Research, 24(1), 1. https://doi.org/10.1186/s12931-023-02497-0

Chicago Style (17th ed.) Citation

McNally, Paul, et al. "The Clinical Impact of Lumacaftor-Ivacaftor on Structural Lung Disease and Lung Function in Children Aged 6–11 with Cystic Fibrosis in a Real-world Setting." Respiratory Research 24, no. 1 (2023): 1. https://doi.org/10.1186/s12931-023-02497-0.

MLA (9th ed.) Citation

McNally, Paul, et al. "The Clinical Impact of Lumacaftor-Ivacaftor on Structural Lung Disease and Lung Function in Children Aged 6–11 with Cystic Fibrosis in a Real-world Setting." Respiratory Research, vol. 24, no. 1, 2023, p. 1, https://doi.org/10.1186/s12931-023-02497-0.